Magnetar Financial LLC Abb Vie Inc. Transaction History

Magnetar Financial LLC

$3.44 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $12.9 Million - $14.8 Million	-95,907 Reduced 96.1%	3,897 $523,000
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $13.7 Million - $17.5 Million	99,804 New	99,804 $15.3 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $11.8 Million - $14.9 Million	-109,971 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $8.08 Million - $9.17 Million	75,944 Added 223.19%	109,971 $11.9 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $3.58 Million - $3.99 Million	34,027 New	34,027 $3.83 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $10.8 Million - $11.9 Million	-105,272 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $15 Million - $20.3 Million	-186,477 Reduced 63.92%	105,272 $11.3 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $18.2 Million - $21.4 Million	211,987 Added 265.77%	291,749 $25.6 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $889,097 - $1.19 Million	12,118 Added 17.91%	79,762 $7.83 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $4 Million - $6.06 Million	61,976 Added 1093.44%	67,644 $5.15 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $6.73 Million - $8.42 Million	-93,271 Reduced 94.27%	5,668 $502,000
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $2.49 Million - $2.99 Million	39,539 Added 66.56%	98,939 $7.49 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $748,980 - $957,372	11,400 Added 23.75%	59,400 $4.32 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $3 Million - $3.55 Million	33,450 Added 229.9%	48,000 $4.45 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $1.34 Million - $1.79 Million	14,550 New	14,550 $1.38 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.

Account